CELL SOURCE INC closed fiscal year 2024 with $287K in total assets, $18.8M in total liabilities and -$18.5M in shareholder equity. This represents an increase of 46.8% from the prior fiscal year. The table below carries 12 fiscal years, from 2013 to 2024, and the quarters CELL SOURCE INC has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
CLCS Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $287K+46.8% | $195K-52.4% | $410K+30.6% | $314K-30.6% | $452K+294.1% | $115K+74.5% | $66K-87.6% | $532K+151.9% | $211K-1.7% | $215K+74.5% | $123K+33.5% | $92K |
| Total Liabilities | $18.8M+19.1% | $15.8M+21.2% | $13.0M+28.6% | $10.1M+20.7% | $8.4M+43.4% | $5.9M+17.5% | $5.0M-2.0% | $5.1M-21.1% | $6.5M+8.1% | $6.0M+52.9% | $3.9M+394.8% | $790K |
| Total Equity | -$18.5M-18.7% | -$15.6M-23.6% | -$12.6M-28.6% | -$9.8M-23.6% | -$7.9M-38.4% | -$5.7M-16.7% | -$4.9M-8.0% | -$4.6M+27.0% | -$6.2M-8.4% | -$5.8M-52.2% | -$3.8M-442.6% | -$697K |
CLCS Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q1'2510-Q | Q4'2410-Q | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q | Q2'2310-Q | Q1'2310-Q | Q4'2210-K | Q3'2210-Q | Q2'2210-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $292K+254.1% | $287K+46.8% | $265K+6.6% | $430K+18.6% | $83K-64.5% | $195K-52.4% | $248K-31.1% | $362K+711.7% | $232K-16.0% | $410K+30.6% | $361K-58.1% | $45K-85.5% |
| Total Liabilities | $20.4M+21.3% | $18.8M+19.1% | $19.2M+18.0% | $17.7M+15.9% | $16.8M+16.5% | $15.8M+21.2% | $16.3M+32.2% | $15.3M+41.6% | $14.5M+40.7% | $13.0M+28.6% | $12.3M+11.5% | $10.8M+4.6% |
| Total Equity | -$20.1M-20.2% | -$18.5M-18.7% | -$18.9M-18.2% | -$17.3M-15.9% | -$16.8M-17.8% | -$15.6M-23.6% | -$16.0M-34.1% | -$14.9M-38.8% | -$14.2M-42.2% | -$12.6M-28.6% | -$12.0M-17.3% | -$10.8M-7.4% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More CELL SOURCE INC financials
Frequently Asked Questions
What was CELL SOURCE INC's total assets in fiscal year 2024?
CELL SOURCE INC closed fiscal year 2024 with $287K in total assets, $18.8M in total liabilities and -$18.5M in shareholder equity.
How fast is CELL SOURCE INC's total assets growing?
CELL SOURCE INC (CLCS) total assets rose by 46.8% year over year, from $195K to $287K in fiscal year 2024.
How has CELL SOURCE INC's total assets changed over the years?
Across the 12 fiscal years this page covers, CELL SOURCE INC (CLCS) total assets went from $92K in fiscal year 2013 to $287K in fiscal year 2024.
What was CELL SOURCE INC's total assets in the most recent quarter?
CELL SOURCE INC (CLCS) reported $292K in total assets in Q1 2025. This represents an increase of 254.1% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what CELL SOURCE INC (CLCS) reported on that line in every period on record.